Eli Lilly and Company (NYSE:LLY) is one of the best Fortune 500 stocks to buy according to billionaires. On June 20, Eli Lilly reported a positive reception for its blockbuster drug Mounjaro in India ...

The NHS have shed light on whether weight loss jab Mounjaro is ready to fight fat in Devon. It comes amid a surge of interest ...

Exclusive: Julie Bishop lost two-and-a-half stone in eight weeks by taking Mounjaro before she was sent to hospital with ...

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...

MHRA says users of jabs such as Wegovy and Mounjaro reported inflamed pancreas - which can cause agonising abdominal pain - ...

Mounjaro has now become available on the NHS for patients in the UK, meaning doctors will have a lot more work on their ...

Hundreds of people in the UK have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to begin a study into side-effects. Some cases ...

Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.

New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show the group of drugs that includes ...

Eli Lilly is grabbing the lead in the fast-growing diabetes drug market. Eli Lilly (NYSE: LLY) has been on fire over the past ...

With obesity and Type 2 diabetes on the rise, India is emerging as a key battleground for global drugmakers developing next-generation therapies targeting metabolic disorders.

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.